SkinMedica scratches up $9.4M for anti-aging pharmaceuticals
SkinMedica, maker of specialized anti-aging treatments, has raised $9.4 million in equity and rights. It adds this amount to the $103.4 million in venture capital it previously brought in from a bevy of investors including Aisling Capital, Apax Partners, Domain Associates, EuclidSR Partners, HealthCare Ventures, Montagu Newhall Associates, Montreux Equity Partners, Split Rock Partners, St. Paul Venture Capital and Windamere Venture Partners.
Based in Carlsbad, Calif., the company last raised capital in 2006, bringing in $11.2 million in a fifth round of funding.
Next Story: Stitcher channels $100K for personalized radio
Previous Story: EMC and NetApp’s battle to buy Data Domain pays off for investors
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
-
Wine Bar Guy
-
Manisha